{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T23:47:23Z","timestamp":1768693643876,"version":"3.49.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2014\/000392"],"award-info":[{"award-number":["EMR\/2014\/000392"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Inorg Chem"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00775-019-01724-8","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T13:04:50Z","timestamp":1571231090000},"page":"1245-1259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Active-site environment of Cu bound amyloid \u03b2 and amylin peptides"],"prefix":"10.1007","volume":"24","author":[{"given":"Ishita","family":"Pal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhuparna","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somdatta Ghosh","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"key":"1724_CR1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/pmj.77.913.686","volume":"77","author":"MF Khan","year":"2001","unstructured":"Khan MF, Falk RH (2001) Amyloidosis. Postgrad Med J 77:686","journal-title":"Postgrad Med J"},{"key":"1724_CR2","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1200\/JCO.2010.32.2271","volume":"29","author":"G Merlini","year":"2011","unstructured":"Merlini G, Seldin DC, Gertz MA (2011) Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol 29:1924\u20131933","journal-title":"J Clin Oncol"},{"key":"1724_CR3","first-page":"837","volume":"43","author":"B Gueft","year":"1963","unstructured":"Gueft B, Ghidoni JJ (1963) The site of formation and ultrastructure of amyloid. Am J Pathol 43:837\u2013854","journal-title":"Am J Pathol"},{"key":"1724_CR4","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1073\/pnas.96.8.4604","volume":"96","author":"E Scherzinger","year":"1999","unstructured":"Scherzinger E, Sittler A, Schweiger K, Heiser V, Lurz R, Hasenbank R, Bates GP, Lehrach H, Wanker EE (1999) Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington\u2019s disease pathology. Proc Natl Acad Sci U S A 96:4604","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1724_CR5","first-page":"890","volume":"94","author":"P Schwartz","year":"1976","unstructured":"Schwartz P (1976) Amyloidosis as a manifestation and origin of presenile and senile degeneration. Fortschr Med 94:890\u2013896","journal-title":"Fortschr Med"},{"key":"1724_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4161\/pri.3.1.8122","volume":"3","author":"MA Mena","year":"2009","unstructured":"Mena MA, Rodr\u00edguez-Navarro JA, de Y\u00e9benes JG (2009) The multiple mechanisms of amyloid deposition: the role of parkin. Prion 3:5\u201311","journal-title":"Prion"},{"key":"1724_CR7","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.2337\/db10-0539","volume":"59","author":"W Xu","year":"2010","unstructured":"Xu W, Caracciolo B, Wang HX, Winblad B, B\u00e4ckman L, Qiu C, Fratiglioni L (2010) Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes 59:2928","journal-title":"Diabetes"},{"key":"1724_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrendo.2010.228","volume":"7","author":"MWJ Strachan","year":"2011","unstructured":"Strachan MWJ, Reynolds RM, Marioni RE, Price JF (2011) Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol 7:108","journal-title":"Nat Rev Endocrinol"},{"key":"1724_CR9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/193229680800200619","volume":"2","author":"SM de la Monte","year":"2008","unstructured":"de la Monte SM, Wands JR (2008) Alzheimer\u2019s disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol 2:1101\u20131113","journal-title":"J Diabetes Sci Technol"},{"key":"1724_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1042\/BST0331041","volume":"33","author":"GJ Biessels","year":"2005","unstructured":"Biessels GJ, Kappelle LJ (2005) Increased risk of Alzheimer\u2019s disease in Type\u00a0II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 33:1041","journal-title":"Biochem Soc Trans"},{"key":"1724_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2147\/CIA.S74042","volume":"10","author":"X Li","year":"2015","unstructured":"Li X, Song D, Leng SX (2015) Link between type 2 diabetes and Alzheimer\u2019s disease: from epidemiology to mechanism and treatment. Clin Interv Aging 10:549\u2013560","journal-title":"Clin Interv Aging"},{"key":"1724_CR12","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1096\/fj.201700431R","volume":"31","author":"N Wijesekara","year":"2017","unstructured":"Wijesekara N, Ahrens R, Sabale M, Wu L, Ha K, Verdile G, Fraser PE (2017) Amyloid-beta and islet amyloid pathologies link Alzheimer\u2019s disease and type 2 diabetes in a transgenic model. FASEB J 31:5409\u20135418","journal-title":"FASEB J"},{"key":"1724_CR13","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1039\/b807980n","volume":"38","author":"A Rauk","year":"2009","unstructured":"Rauk A (2009) The chemistry of Alzheimer\u2019s disease. Chem Soc Rev 38:2698\u20132715","journal-title":"Chem Soc Rev"},{"key":"1724_CR14","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 82:4245","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1724_CR15","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, Strooper BD (2011) The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10:698","journal-title":"Nat Rev Drug Discov"},{"key":"1724_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O\u2019Brien","year":"2011","unstructured":"O\u2019Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci 34:185\u2013204","journal-title":"Annu Rev Neurosci"},{"key":"1724_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-2990.1999.00164.x","volume":"25","author":"N Storey","year":"2002","unstructured":"Storey N, Cappai N (2002) The amyloid precursor protein of Alzheimer\u2019s disease and the A\u03b2 peptide. Neuropathol Appl Neurobiol 25:81\u201397","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1724_CR18","doi-asserted-by":"publisher","first-page":"8378","DOI":"10.1073\/pnas.91.18.8378","volume":"91","author":"J Naslund","year":"1994","unstructured":"Naslund J, Schierhorn A, Hellman U, Lannfelt L, Roses A, Tjernberg L, Silberring J, Gandy S, Winblad B, Greengard P et al (1994) Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci U S A 91:8378\u20138382","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1724_CR19","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","volume":"101","author":"DM Walsh","year":"2007","unstructured":"Walsh DM, Selkoe DJ (2007) A\u03b2 oligomers\u2014a decade of discovery. J Neurochem 101:1172\u20131184","journal-title":"J Neurochem"},{"key":"1724_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/0972-2327.150606","volume":"18","author":"M Verma","year":"2015","unstructured":"Verma M, Vats A, Taneja V (2015) Toxic species in amyloid disorders: oligomers or mature fibrils. Ann Indian Acad Neurol 18:138\u2013145","journal-title":"Ann Indian Acad Neurol"},{"key":"1724_CR21","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1742-4658.2010.07568.x","volume":"277","author":"M Sakono","year":"2010","unstructured":"Sakono M, Zako T (2010) Amyloid oligomers: formation and toxicity of Abeta oligomers. FEBS J 277:1348\u20131358","journal-title":"FEBS J"},{"key":"1724_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1750-3639.2005.tb00101.x","volume":"15","author":"AC Cuello","year":"2005","unstructured":"Cuello AC (2005) Intracellular and extracellular A\u03b2, a tale of two neuropathologies. Brain Pathol 15:66\u201371","journal-title":"Brain Pathol"},{"key":"1724_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2174\/156720508786898514","volume":"5","author":"Y Ohyagi","year":"2008","unstructured":"Ohyagi Y (2008) Intracellular amyloid beta-protein as a therapeutic target for treating Alzheimer\u2019s disease. Curr Alzheimer Res 5:555\u2013561","journal-title":"Curr Alzheimer Res"},{"key":"1724_CR24","first-page":"339","volume":"19","author":"CR Cornett","year":"1998","unstructured":"Cornett CR, Markesbery WR, Ehmann WD (1998) Imbalances of trace elements related to oxidative damage in Alzheimer\u2019s disease brain. Neurotoxicology 19:339\u2013345","journal-title":"Neurotoxicology"},{"key":"1724_CR25","doi-asserted-by":"publisher","first-page":"11193","DOI":"10.1073\/pnas.2135061100","volume":"100","author":"AI Bush","year":"2003","unstructured":"Bush AI, Masters CL, Tanzi RE (2003) Copper, \u03b2-amyloid, and Alzheimer\u2019s disease: tapping a sensitive connection. Proc Natl Acad Sci 100:11193","journal-title":"Proc Natl Acad Sci"},{"key":"1724_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acschemneuro.6b00362","volume":"8","author":"SA James","year":"2017","unstructured":"James SA, Churches QI, de Jonge MD, Birchall IE, Streltsov V, McColl G, Adlard PA, Hare DA (2017) Iron, copper, and zinc concentration in abeta plaques in the APP\/PS1 mouse model of Alzheimer\u2019s disease correlates with metal levels in the surrounding neuropil. ACS Chem Neurosci 8:629\u2013637","journal-title":"ACS Chem Neurosci"},{"key":"1724_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.0959-9673.2005.00434.x","volume":"86","author":"CJ Maynard","year":"2005","unstructured":"Maynard CJ, Bush AI, Masters CL, Cappai R, Li Q (2005) Metals and amyloid-beta in Alzheimer\u2019s disease. Int J Exp Pathol 86:147\u2013159","journal-title":"Int J Exp Pathol"},{"key":"1724_CR28","doi-asserted-by":"publisher","first-page":"11193","DOI":"10.1073\/pnas.2135061100","volume":"100","author":"AI Bush","year":"2003","unstructured":"Bush AI, Masters CL, Tanzi RE (2003) Copper, \u03b2-amyloid, and Alzheimer\u2019s disease: tapping a sensitive connection. Proc Natl Acad Sci U S A 100:11193\u201311194","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1724_CR29","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1021\/cr040410w","volume":"106","author":"E Gaggelli","year":"2006","unstructured":"Gaggelli E, Kozlowski H, Valensin G (2006) Copper homeostasis and neurodegenerative disorders (Alzheimer\u2019s, prion, and Parkinson\u2019s diseases and amyotrophic lateral sclerosis). Chem Rev 106:1995\u20132040","journal-title":"Chem Rev"},{"key":"1724_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-3-319-60189-2_10","volume":"18","author":"ZK Mathys","year":"2017","unstructured":"Mathys ZK, White AR (2017) Copper and Alzheimer\u2019s disease. Adv Neurobiol 18:199\u2013216","journal-title":"Adv Neurobiol"},{"key":"1724_CR31","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1212\/WNL.59.8.1153","volume":"59","author":"R Squitti","year":"2002","unstructured":"Squitti R, Lupoi D, Pasqualetti P, Dal Forno G, Vernieri F, Chiovenda P, Rossi L, Cortesi M, Cassetta E, Rossini PM (2002) Elevation of serum copper levels in Alzheimer\u2019s disease. Neurology 59:1153","journal-title":"Neurology"},{"key":"1724_CR32","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1126\/science.271.5254.1406","volume":"271","author":"G Multhaup","year":"1996","unstructured":"Multhaup G, Schlicksupp A, Hesse L, Beher D, Ruppert T, Masters CL, Beyreuther K (1996) The amyloid precursor protein of Alzheimer\u2019s disease in the reduction of copper(II) to copper(I). Science 271:1406","journal-title":"Science"},{"key":"1724_CR33","first-page":"46","volume":"2","author":"R Squitti","year":"2013","unstructured":"Squitti R, Polimanti R (2013) Copper phenotype in Alzheimer\u2019s disease: dissecting the pathway. Am J Neurodegener Dis 2:46\u201356","journal-title":"Am J Neurodegener Dis"},{"key":"1724_CR34","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.mam.2005.07.015","volume":"26","author":"JY Uriu-Adams","year":"2005","unstructured":"Uriu-Adams JY, Keen CL (2005) Copper, oxidative stress, and human health. Mol Aspects Med 26:268\u2013298","journal-title":"Mol Aspects Med"},{"key":"1724_CR35","doi-asserted-by":"crossref","unstructured":"Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA (2010) Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Med Inflamm 2010 (2010)","DOI":"10.1155\/2010\/453892"},{"key":"1724_CR36","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc10-S062","volume":"33","author":"AD Association","year":"2010","unstructured":"Association AD (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33:S62","journal-title":"Diabetes Care"},{"key":"1724_CR37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KGMM Alberti","year":"1998","unstructured":"Alberti KGMM, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15:539\u2013553","journal-title":"Diabet Med"},{"key":"1724_CR38","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.2337\/db13-1954","volume":"63","author":"FG De Felice","year":"2014","unstructured":"De Felice FG, Ferreira ST (2014) Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes 63:2262","journal-title":"Diabetes"},{"key":"1724_CR39","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbadis.2008.10.014","volume":"1792","author":"WQ Zhao","year":"2009","unstructured":"Zhao WQ, Townsend M (2009) Townsend, Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer\u2019s disease. Biochim et Biophys Acta (BBA) Mol Basis Dis 1792:482\u2013496","journal-title":"Biochim et Biophys Acta (BBA) Mol Basis Dis"},{"key":"1724_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0925-4439(01)00078-3","volume":"1537","author":"ETAS Jaikaran","year":"2001","unstructured":"Jaikaran ETAS, Clark A (2001) Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim et Biophys Acta (BBA) Mol Basis Dis 1537:179\u2013203","journal-title":"Biochim et Biophys Acta (BBA) Mol Basis Dis"},{"key":"1724_CR41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) \u03b2-cell deficit and increased \u03b2-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102","journal-title":"Diabetes"},{"key":"1724_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13410-013-0130-6","volume":"33","author":"F Bozkurt","year":"2013","unstructured":"Bozkurt F, Tekin R, Gulsun S, Sat\u0131c\u0131 \u00d6, Deveci O, Hosoglu S (2013) The levels of copper, zinc and magnesium in type II diabetic patients complicated with foot infections. Int J Diabetes Dev Ctries 33:165\u2013169","journal-title":"Int J Diabetes Dev Ctries"},{"key":"1724_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jinorgbio.2014.07.002","volume":"140","author":"L Ma","year":"2014","unstructured":"Ma L, Li X, Wang Y, Zheng W, Chen T (2014) Cu(II) inhibits hIAPP fibrillation and promotes hIAPP-induced beta cell apoptosis through induction of ROS-mediated mitochondrial dysfunction. J Inorg Biochem 140:143\u2013152","journal-title":"J Inorg Biochem"},{"key":"1724_CR44","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jinorgbio.2007.09.010","volume":"102","author":"B Ward","year":"2008","unstructured":"Ward B, Walker K, Exley C (2008) Copper(II) inhibits the formation of amylin amyloid in vitro. J Inorg Biochem 102:371\u2013375","journal-title":"J Inorg Biochem"},{"key":"1724_CR45","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.1039\/C6SC00153J","volume":"7","author":"SJC Lee","year":"2016","unstructured":"Lee SJC, Choi TS, Lee JW, Lee HJ, Mun DG, Akashi S, Lee SW, Lim MH, Kim HI (2016) Structure and assembly mechanisms of toxic human islet amyloid polypeptide oligomers associated with copper. Chem Sci 7:5398\u20135406","journal-title":"Chem Sci"},{"key":"1724_CR46","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1039\/C4MT00130C","volume":"6","author":"A Sinopoli","year":"2014","unstructured":"Sinopoli A, Magr\u00ec A, Milardi D, Pappalardo M, Pucci P, Flagiello A, Titman JJ, Nicoletti VG, Caruso G, Pappalardo G, Grasso G (2014) The role of copper(ii) in the aggregation of human amylin. Metallomics 6:1841\u20131852","journal-title":"Metallomics"},{"key":"1724_CR47","doi-asserted-by":"publisher","first-page":"6909","DOI":"10.1039\/c0cc02141e","volume":"46","author":"YP Yu","year":"2010","unstructured":"Yu YP, Lei P, Hu J, Wu WH, Zhao YF, Li YM (2010) Copper-induced cytotoxicity: reactive oxygen species or islet amyloid polypeptide oligomer formation. Chem Commun 46:6909\u20136911","journal-title":"Chem Commun"},{"key":"1724_CR48","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1016\/j.febslet.2007.06.061","volume":"581","author":"A Masad","year":"2007","unstructured":"Masad A, Hayes L, Tabner B, Turnbull S, Cooper LJ, Fullwood NJ, German MJ, Kametani F, El-Agnaf OM, Allsop D (2007) Copper-mediated formation of hydrogen peroxide from the amylin peptide: a novel mechanism for degeneration of islet cells in type-2 diabetes mellitus? FEBS Lett 581:3489\u20133493","journal-title":"FEBS Lett"},{"key":"1724_CR49","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1021\/ic301865n","volume":"52","author":"C Ghosh","year":"2013","unstructured":"Ghosh C, Dey SG (2013) Ligand-field and ligand-binding analysis of the active site of copper-bound A\u03b2 associated with Alzheimer\u2019s disease. Inorg Chem 52:1318\u20131327","journal-title":"Inorg Chem"},{"key":"1724_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1021\/acs.inorgchem.7b02266","volume":"57","author":"M Seal","year":"2018","unstructured":"Seal M, Dey SG (2018) Active-site environment of copper-bound human amylin relevant to type 2 diabetes. Inorg Chem 57:129\u2013138","journal-title":"Inorg Chem"},{"key":"1724_CR51","doi-asserted-by":"publisher","first-page":"9273","DOI":"10.1002\/anie.200904567","volume":"48","author":"P Dorlet","year":"2009","unstructured":"Dorlet P, Faller GSP, Hureau C (2009) Pulse EPR spectroscopy reveals the coordination sphere of copper(II) ions in the 1-16 amyloid-beta peptide: a key role of the first two N-terminus residues. Angew Chem Int Ed Engl 48:9273\u20139276","journal-title":"Angew Chem Int Ed Engl"},{"key":"1724_CR52","doi-asserted-by":"publisher","first-page":"10727","DOI":"10.1021\/acs.inorgchem.6b01963","volume":"55","author":"C S\u00e1nchez-L\u00f3pez","year":"2016","unstructured":"S\u00e1nchez-L\u00f3pez C, Cort\u00e9s-Mej\u00eda R, Miotto MC, Binolfi A, Fern\u00e1ndez CO, del Campo JM, Quintanar L (2016) Copper coordination features of human islet amyloid polypeptide: the type 2 diabetes peptide. Inorg Chem 55:10727\u201310740","journal-title":"Inorg Chem"},{"key":"1724_CR53","doi-asserted-by":"crossref","first-page":"797S","DOI":"10.1093\/ajcn\/63.5.797","volume":"63","author":"MC Linder","year":"1996","unstructured":"Linder MC, Hazegh-Azam M (1996) Copper biochemistry and molecular biology. Am J Clin Nutr 63:797S\u2013811S","journal-title":"Am J Clin Nutr"},{"key":"1724_CR54","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/anie.201005838","volume":"50","author":"H Eury","year":"2011","unstructured":"Eury H, Bijani C, Faller P, Hureau C (2011) Copper(II) coordination to amyloid\u2005\u03b2: murine versus human peptide. Angew Chem Int Ed 50:901\u2013905","journal-title":"Angew Chem Int Ed"},{"key":"1724_CR55","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1021\/bi047611e","volume":"44","author":"JW Karr","year":"2005","unstructured":"Karr JW, Akintoye H, Kaupp LJ, Szalai VA (2005) N-Terminal deletions modify the Cu2\u2009+\u2009binding site in amyloid-beta. Biochemistry 44:5478\u20135487","journal-title":"Biochemistry"},{"key":"1724_CR56","doi-asserted-by":"publisher","first-page":"10784","DOI":"10.1074\/jbc.M707109200","volume":"283","author":"V Minicozzi","year":"2008","unstructured":"Minicozzi V, Stellato F, Comai M, Dalla SM, Potrich C, Meyer-Klaucke W, Morante S (2008) Identifying the minimal copper- and zinc-binding site sequence in amyloid-beta peptides. J Biol Chem 283:10784\u201310792","journal-title":"J Biol Chem"},{"key":"1724_CR57","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1021\/ar200014u","volume":"44","author":"SC Drew","year":"2011","unstructured":"Drew SC, Barnham KJ (2011) The heterogeneous nature of Cu2\u2009+\u2009interactions with Alzheimer\u2019s amyloid-beta peptide. Acc Chem Res 44:1146\u20131155","journal-title":"Acc Chem Res"},{"key":"1724_CR58","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1039\/B813398K","volume":"21","author":"P Faller","year":"2009","unstructured":"Faller P, Hureau C (2009) Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide. Dalton Trans 21:1080\u20131094","journal-title":"Dalton Trans"},{"key":"1724_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ejic.201700776","volume":"2018","author":"V Borghesani","year":"2018","unstructured":"Borghesani V, Alies B, Hureau C (2018) Cu(II) binding to various forms of amyloid-\u03b2 peptides. Are they friends or foes? Eur J Inorg Chem 2018:7\u201315","journal-title":"Eur J Inorg Chem"},{"key":"1724_CR60","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1021\/ja068952d","volume":"129","author":"JW Karr","year":"2007","unstructured":"Karr JW, Szalai VA (2007) Role of aspartate-1 in Cu(II) binding to the amyloid-beta peptide of Alzheimer\u2019s disease. J Am Chem Soc 129:3796\u20133797","journal-title":"J Am Chem Soc"},{"key":"1724_CR61","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1021\/ja808073b","volume":"131","author":"SC Drew","year":"2009","unstructured":"Drew SC, Noble CJ, Masters CL, Hanson GL, Barnham KJ (2009) Pleomorphic copper coordination by Alzheimer\u2019s disease amyloid-beta peptide. J Am Chem Soc 131:1195\u20131207","journal-title":"J Am Chem Soc"},{"key":"1724_CR62","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s00775-006-0154-1","volume":"11","author":"L Guilloreau","year":"2006","unstructured":"Guilloreau L, Damian L, Coppel Y, Mazarguil H, Winterhalter M, Faller P (2006) Structural and thermodynamical properties of CuII amyloid-\u03b216\/28 complexes associated with Alzheimer\u2019s disease. J Biol Inorg Chem 11:1024\u20131038","journal-title":"J Biol Inorg Chem"},{"key":"1724_CR63","doi-asserted-by":"publisher","first-page":"18169","DOI":"10.1074\/jbc.M313572200","volume":"279","author":"CD Syme","year":"2004","unstructured":"Syme CD, Nadal RC, Rigby SEJ, Viles JH (2004) Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer\u2019s disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques. J Biol Chem 279:18169\u201318177","journal-title":"J Biol Chem"},{"key":"1724_CR64","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1074\/jbc.M205455200","volume":"278","author":"CC Curtain","year":"2003","unstructured":"Curtain CC, Ali FF, Smith DG, Bush AI, Masters CL, Barnham KJ (2003) Metal ions, pH, and cholesterol regulate the interactions of Alzheimer\u2019s disease amyloid-beta peptide with membrane lipid. J Biol Chem 278:2977\u20132982","journal-title":"J Biol Chem"},{"key":"1724_CR65","doi-asserted-by":"publisher","first-page":"11192","DOI":"10.1021\/ic201739n","volume":"50","author":"B Alies","year":"2011","unstructured":"Alies B, Eury C, Bijani H, Rechignat L, Faller P, Hureau C (2011) pH-Dependent Cu(II) coordination to amyloid-beta peptide: impact of sequence alterations, including the H6R and D7\u00a0N familial mutations. Inorg Chem 50:11192\u201311201","journal-title":"Inorg Chem"},{"key":"1724_CR66","doi-asserted-by":"publisher","first-page":"9522","DOI":"10.1002\/anie.200904512","volume":"48","author":"C Hureau","year":"2009","unstructured":"Hureau C, Coppel Y, Dorlet P, Solari PL, Sayen S, Guillon E, Sabater L, Faller P (2009) Deprotonation of the Asp1-Ala2 peptide bond induces modification of the dynamic copper(II) environment in the amyloid-beta peptide near physiological pH. Angew Chem Int Ed Engl 48:9522\u20139525","journal-title":"Angew Chem Int Ed Engl"},{"key":"1724_CR67","doi-asserted-by":"publisher","first-page":"7960","DOI":"10.1021\/ic301244x","volume":"51","author":"YP Ginotra","year":"2012","unstructured":"Ginotra YP, Ramteke SN, Srikanth R, Kulkarni PP (2012) Mass spectral studies reveal the structure of A\u03b21\u201316\u2013Cu2\u2009+\u2009complex resembling ATCUN Motif. Inorg Chem 51:7960\u20137962","journal-title":"Inorg Chem"},{"key":"1724_CR68","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1039\/C4MT00001C","volume":"6","author":"TR Young","year":"2014","unstructured":"Young TR, Kirchner A, Wedd AG, Xiao Z (2014) An integrated study of the affinities of the A\u03b216 peptide for Cu(i) and Cu(ii): implications for the catalytic production of reactive oxygen species. Metallomics 6:505\u2013517","journal-title":"Metallomics"},{"key":"1724_CR69","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0162-0134(03)00128-4","volume":"95","author":"T Kowalik-Jankowska","year":"2003","unstructured":"Kowalik-Jankowska T, Ruta M, Wi\u015bniewska K, Lankiewicz L (2003) Coordination abilities of the 1\u201316 and 1\u201328 fragments of beta-amyloid peptide towards copper(II) ions: a combined potentiometric and spectroscopic study. J Inorg Biochem 95:270\u2013282","journal-title":"J Inorg Biochem"},{"key":"1724_CR70","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1039\/dt9780001269","volume":"5","author":"I Bertini","year":"1978","unstructured":"Bertini I, Canti G, Luchinat C, Scozzafava A (1978) Spectroscopic investigation of copper(II) bovine carbonic anhydrase and its inhibitor derivatives. J Chem Soc Dalton Trans 5:1269\u20131273","journal-title":"J Chem Soc Dalton Trans"},{"key":"1724_CR71","doi-asserted-by":"publisher","first-page":"9441","DOI":"10.1021\/ja00142a010","volume":"117","author":"MJ Young","year":"1995","unstructured":"Young MJ, Wahnon D, Hynes RC, Chin J (1995) Reactivity of copper(II) hydroxides and copper(II) alkoxides for cleaving an activated phosphate diester. J Am Chem Soc 117:9441\u20139447","journal-title":"J Am Chem Soc"},{"key":"1724_CR72","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1021\/ja00315a030","volume":"106","author":"JT Groves","year":"1984","unstructured":"Groves JT, Rife R, Chambers R (1984) Geometrical and stereochemical factors in metal-promoted amide hydrolysis. J Am Chem Soc 106:630\u2013638","journal-title":"J Am Chem Soc"},{"issue":"4","key":"1724_CR73","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1021\/ja017899k","volume":"125","author":"Sei'ichiro Kishishita","year":"2003","unstructured":"Kishishita S, Okajima T, Kim M, Yamaguchi H, Hirota S, Suzuki S, Kuroda S, Tanizawa K, Mure M (2003) Role of copper ion in bacterial copper amine oxidase: spectroscopic and crystallographic studies of metal-substituted enzymes. J Am Chem Soc 125 (2003)","journal-title":"Journal of the American Chemical Society"},{"key":"1724_CR74","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1529\/biophysj.108.134429","volume":"95","author":"VA Streltsov","year":"2008","unstructured":"Streltsov VA, Titmuss SJ, Epa VC, Barnham KJ, Masters CL, Varghese JN (2008) The structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease. Biophys J 95:3447\u20133456","journal-title":"Biophys J"},{"key":"1724_CR75","doi-asserted-by":"publisher","first-page":"11899","DOI":"10.1021\/jp308977s","volume":"116","author":"S Furlan","year":"2012","unstructured":"Furlan S, Hureau C, Faller P, La Penna G (2012) Modeling copper binding to the amyloid-\u03b2 peptide at different pH: toward a molecular mechanism for Cu reduction. J Phys Chem B 116:11899\u201311910","journal-title":"J Phys Chem B"},{"key":"1724_CR76","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jcb.240550004","volume":"55","author":"RA Pittner","year":"1994","unstructured":"Pittner RA, Albrandt K, Beaumont K, Gaeta LSL, Koda JE, Moore CX, Rittenhouse J, Rink TJ (1994) Molecular physiology of amylin. J Cell Biochem 55:19\u201328","journal-title":"J Cell Biochem"},{"key":"1724_CR77","doi-asserted-by":"publisher","first-page":"8099","DOI":"10.1039\/C6DT00628K","volume":"45","author":"M Rowi\u0144ska-\u017byrek","year":"2016","unstructured":"Rowi\u0144ska-\u017byrek M (2016) Coordination of Zn2\u2009+\u2009and Cu2\u2009+\u2009to the membrane disrupting fragment of amylin. Dalton Trans 45:8099\u20138106","journal-title":"Dalton Trans"},{"key":"1724_CR78","doi-asserted-by":"crossref","unstructured":"Daniele PG, Prenesti E, Ostacoli G (1996) Ultraviolet\u2013circular dichroism spectra for structural analysis of copper(II) complexes with aliphatic and aromatic ligands in aqueous solution. J Chem Soc Dalton Trans 0:3269\u20133275","DOI":"10.1039\/DT9960003269"},{"key":"1724_CR79","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1073\/pnas.0407881102","volume":"102","author":"RM Rasia","year":"2005","unstructured":"Rasia RM, Bertoncini CW, Marsh D, Hoyer W, Cherny D, Zweckstetter M, Griesinger C, Jovin TM, Fernandez CO (2005) Structural characterization of copper(II) binding to alpha-synuclein: insights into the bioinorganic chemistry of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 102:4294\u20134299","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1724_CR80","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1021\/ja204628b","volume":"133","author":"D Pramanik","year":"2011","unstructured":"Pramanik D, Ghosh C, Dey SG (2011) Heme\u2013Cu Bound A\u03b2 Peptides: spectroscopic characterization, reactivity, and relevance to Alzheimer\u2019s disease. J Am Chem Soc 133:15545\u201315552","journal-title":"J Am Chem Soc"},{"key":"1724_CR81","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1021\/ja993774s","volume":"122","author":"KM McCauley","year":"2000","unstructured":"McCauley KM, Vrtis JM, Dupont J, van der Donk WA (2000) Insights into the functional role of the tyrosine\u2013histidine linkage in cytochrome c oxidase. J Am Chem Soc 122:2403\u20132404","journal-title":"J Am Chem Soc"},{"key":"1724_CR82","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1021\/ja5109936","volume":"137","author":"Y Yu","year":"2015","unstructured":"Yu Y, Lv X, Li J, Zhou Q, Cui C, Hosseinzadeh P, Mukherjee A, Nilges MJ, Wang J, Lu Y (2015) Defining the role of tyrosine and rational tuning of oxidase activity by genetic incorporation of unnatural tyrosine analogs. J Am Chem Soc 137:4594\u20134597","journal-title":"J Am Chem Soc"},{"key":"1724_CR83","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1529\/biophysj.105.076984","volume":"90","author":"H Ishikita","year":"2006","unstructured":"Ishikita H, Knapp EW (2006) Function of redox-active tyrosine in photosystem II. Biophys J 90:3886\u20133896","journal-title":"Biophys J"},{"key":"1724_CR84","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1021\/ic302131n","volume":"52","author":"C Ghosh","year":"2013","unstructured":"Ghosh C, Pramanik D, Mukherjee S, Dey A, Dey SG (2013) Interaction of NO with Cu and heme-bound Abeta peptides associated with Alzheimer\u2019s disease. Inorg Chem 52:362\u2013368","journal-title":"Inorg Chem"}],"container-title":["JBIC Journal of Biological Inorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-019-01724-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00775-019-01724-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-019-01724-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T02:54:46Z","timestamp":1721876086000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00775-019-01724-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"references-count":84,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1724"],"URL":"https:\/\/doi.org\/10.1007\/s00775-019-01724-8","relation":{},"ISSN":["0949-8257","1432-1327"],"issn-type":[{"value":"0949-8257","type":"print"},{"value":"1432-1327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,16]]},"assertion":[{"value":"15 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There are no conflicts to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}